FY2025 EPS Estimates for CRSP Cut by Cantor Fitzgerald
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Investment analysts at Cantor Fitzgerald cut their FY2025 earnings per share estimates for CRISPR Therapeutics in a research note issued on Wednesday, February 19th. Cantor Fitzgerald analyst E. Schmidt now expects that the company will earn ($6.91) per share for the year, down from their prior estimate […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Investment analysts at Cantor Fitzgerald cut their FY2025 earnings per share estimates for CRISPR Therapeutics in a research note issued on Wednesday, February 19th. Cantor Fitzgerald analyst E. Schmidt now expects that the company will earn ($6.91) per share for the year, down from their prior estimate […]
